📖 The Full Spectrum of #Immunoassays
From assay design to troubleshooting and regulatory frameworks—now in one comprehensive reference:
👉 doi.org/10.1007/978-...
#Diagnostics #Antibodies #ProteinAnalysis #AssayDevelopment #IVDR
From assay design to troubleshooting and regulatory frameworks—now in one comprehensive reference:
👉 doi.org/10.1007/978-...
#Diagnostics #Antibodies #ProteinAnalysis #AssayDevelopment #IVDR
June 5, 2026 at 6:33 AM
📖 The Full Spectrum of #Immunoassays
From assay design to troubleshooting and regulatory frameworks—now in one comprehensive reference:
👉 doi.org/10.1007/978-...
#Diagnostics #Antibodies #ProteinAnalysis #AssayDevelopment #IVDR
From assay design to troubleshooting and regulatory frameworks—now in one comprehensive reference:
👉 doi.org/10.1007/978-...
#Diagnostics #Antibodies #ProteinAnalysis #AssayDevelopment #IVDR
At Inaphaea, we offer cells for purchase and testing services across our biobank of 478 Patient Derived Cell Models, representing 66 cancer indications, including 31 prostate cancer PDCs with RNS-seq data.
View more on our website: https://bit.ly/3SINi9o
##MensHealthWeek #Assays #AssayDevelopment
View more on our website: https://bit.ly/3SINi9o
##MensHealthWeek #Assays #AssayDevelopment
June 11, 2025 at 11:00 AM
At Inaphaea, we offer cells for purchase and testing services across our biobank of 478 Patient Derived Cell Models, representing 66 cancer indications, including 31 prostate cancer PDCs with RNS-seq data.
View more on our website: https://bit.ly/3SINi9o
##MensHealthWeek #Assays #AssayDevelopment
View more on our website: https://bit.ly/3SINi9o
##MensHealthWeek #Assays #AssayDevelopment
"Sister - I am not there for that." iconYann's take on running multiple instruments and conditions for assay development experiments. Developing assays? Get on the #iconPCR train and majorly change your workflow and efficiency! #assaydevelopment #AutoNorm
July 11, 2025 at 11:27 AM
"Sister - I am not there for that." iconYann's take on running multiple instruments and conditions for assay development experiments. Developing assays? Get on the #iconPCR train and majorly change your workflow and efficiency! #assaydevelopment #AutoNorm
🧬 Most failed drugs weren’t bad ideas.
They were greenlit by weak, noisy, or misaligned assays.
We don’t have a molecule problem.
We have a signal fidelity problem.
And it's costing us billions.
1 / 2
#DrugDiscovery #AssayDevelopment #Biotech
They were greenlit by weak, noisy, or misaligned assays.
We don’t have a molecule problem.
We have a signal fidelity problem.
And it's costing us billions.
1 / 2
#DrugDiscovery #AssayDevelopment #Biotech
May 20, 2025 at 6:43 PM
🧬 Most failed drugs weren’t bad ideas.
They were greenlit by weak, noisy, or misaligned assays.
We don’t have a molecule problem.
We have a signal fidelity problem.
And it's costing us billions.
1 / 2
#DrugDiscovery #AssayDevelopment #Biotech
They were greenlit by weak, noisy, or misaligned assays.
We don’t have a molecule problem.
We have a signal fidelity problem.
And it's costing us billions.
1 / 2
#DrugDiscovery #AssayDevelopment #Biotech
Proteintech’s Matched Antibody Pairs are the perfect tools for assay building.
Browse through our offering of over 4100 pairs, the largest in the industry, and get closer to a viable assay product.
Learn more: https://bit.ly/4t7zJRA
#antibodies #lifescience #assaydevelopment
Browse through our offering of over 4100 pairs, the largest in the industry, and get closer to a viable assay product.
Learn more: https://bit.ly/4t7zJRA
#antibodies #lifescience #assaydevelopment
April 13, 2026 at 8:20 PM
Proteintech’s Matched Antibody Pairs are the perfect tools for assay building.
Browse through our offering of over 4100 pairs, the largest in the industry, and get closer to a viable assay product.
Learn more: https://bit.ly/4t7zJRA
#antibodies #lifescience #assaydevelopment
Browse through our offering of over 4100 pairs, the largest in the industry, and get closer to a viable assay product.
Learn more: https://bit.ly/4t7zJRA
#antibodies #lifescience #assaydevelopment
How Microplate Readers Are Transforming Modern Laboratory Research: Modern laboratories depend on instruments that can process data quickly, accurately, and across many samples at once. Among these… #MicroplateReaders #LaboratoryResearch #BiomedicalResearch #AutomationInScience #AssayDevelopment
How Microplate Readers Are Transforming Modern Laboratory Research
Modern laboratories depend on instruments that can process data quickly, accurately, and across many samples at once. Among these instruments, the microplate reader has become a centerpiece of experimental design in disciplines ranging from biomedical research to environmental monitoring. By combining automation with precision, these devices allow scientists to handle complex assays that once required […]
The post How Microplate Readers Are Transforming Modern Laboratory Research first appeared on Flowster.
dlvr.it
August 19, 2025 at 4:48 PM
How Microplate Readers Are Transforming Modern Laboratory Research: Modern laboratories depend on instruments that can process data quickly, accurately, and across many samples at once. Among these… #MicroplateReaders #LaboratoryResearch #BiomedicalResearch #AutomationInScience #AssayDevelopment
Inside the bead. Outside the bead. We customize EITHER.
Need your nano- or micron-sized particles to do something no one else can?
Let's partner to build the reagent you need for your assay:
bangslabs.com/support/cust...
#Microparticles #AssayDevelopment #FluorescentBeads #Diagnostics
Need your nano- or micron-sized particles to do something no one else can?
Let's partner to build the reagent you need for your assay:
bangslabs.com/support/cust...
#Microparticles #AssayDevelopment #FluorescentBeads #Diagnostics
March 2, 2026 at 2:09 PM
Inside the bead. Outside the bead. We customize EITHER.
Need your nano- or micron-sized particles to do something no one else can?
Let's partner to build the reagent you need for your assay:
bangslabs.com/support/cust...
#Microparticles #AssayDevelopment #FluorescentBeads #Diagnostics
Need your nano- or micron-sized particles to do something no one else can?
Let's partner to build the reagent you need for your assay:
bangslabs.com/support/cust...
#Microparticles #AssayDevelopment #FluorescentBeads #Diagnostics
Domainex has successfully developed a #competition based spectral shift assay for ATP-competitive inhibitors for several #kinases.
Read the full case study here: www.domainex.co.uk/drug-discove...
#SpectralShift #CompetitionAssay #AssayDevelopment
Read the full case study here: www.domainex.co.uk/drug-discove...
#SpectralShift #CompetitionAssay #AssayDevelopment
April 4, 2025 at 11:00 AM
Domainex has successfully developed a #competition based spectral shift assay for ATP-competitive inhibitors for several #kinases.
Read the full case study here: www.domainex.co.uk/drug-discove...
#SpectralShift #CompetitionAssay #AssayDevelopment
Read the full case study here: www.domainex.co.uk/drug-discove...
#SpectralShift #CompetitionAssay #AssayDevelopment
<a href="https://bsky.app/profile/did:plc:tcr6zo75ruovrhenchyhrzxy" class="hover:underline text-blue-600 dark:text-sky-400 no-card-link" target="_blank" rel="noopener" data-link="bsky-mention">@sennoma lie in the application, explain in the cover letter
Bill Hooker (@sennoma@chaos.social)
16.6K Posts, 1.2K Following, 833 Followers · Thinkmonkey for hire. He/him; they/them is also fine.
Biologist, humanist, atheist, democratic socialist; anarcho-curious.
Science, art, culture, literature, film, music, poetry, photography, chocolate, beer.
If I follow you it's because you said something funny, insightful, or both, and I'm hoping you'll do it again.
Ceterum censeo, Elsevier delenda est.
#OpenScience, #Biotech, #AssayDevelopment, #InVitroDiagnostics, #WorkerOwned, #AntiFascist
https://justmytoots.com/@sennoma@chaos.social
chaos.social
February 18, 2025 at 4:41 PM
<a href="https://bsky.app/profile/did:plc:tcr6zo75ruovrhenchyhrzxy" class="hover:underline text-blue-600 dark:text-sky-400 no-card-link" target="_blank" rel="noopener" data-link="bsky-mention">@sennoma lie in the application, explain in the cover letter